Aziz Mottiwala, Chief Commercial Officer at Tarsus Pharmaceuticals, Inc. (TARS), sold 100 shares at $20.00 ($2K) on 2023-06-08, disclosed to the SEC on 2023-06-12.
Scheduled sale ($2k) by Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| TARS | SELL | 2025-03-20 | $1.0M | — | Filing → |
| TARS | SELL | 2024-03-19 | $292K | — | Filing → |
| TARS | SELL | 2023-07-21 | $48K | — | Filing → |